We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

115 hedge funds and large institutions have $858M invested in Genomic Health, Inc. in 2013 Q2 according to their latest regulatory filings, with 115 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

55% less call options, than puts

Call options by funds: $2.69M | Put options by funds: $6M

Holders
115
Holders Change
+115
Holders Change %
–
% of All Funds
3.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
115
Increased
–
Reduced
–
Closed
–
Calls
$2.69M
Puts
$6M
Net Calls
-$3.31M
Net Calls Change
-$3.31M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ILIM
101
Irish Life Investment Managers
Ireland
$29.4K +$30.4K +927 New
Mitsubishi UFJ Asset Management
102
Mitsubishi UFJ Asset Management
Japan
$29K +$29.6K +900 New
LTFS
103
Ladenburg Thalmann Financial Services
Florida
$23K +$24.1K +734 New
Creative Planning
104
Creative Planning
Kansas
$22K +$23K +700 New
FNBT
105
FineMark National Bank & Trust
Florida
$20K +$20.7K +631 New
WA
106
WFG Advisors
Texas
$16K +$16.4K +500 New
BlackRock
107
BlackRock
New York
$13K +$13.6K +413 New
FHA
108
First Horizon Advisors
Tennessee
$12K +$12.6K +385 New
CCM
109
Credo Capital Management
Maryland
$10K +$10.1K +307 New
TCOV
110
Trust Company of Vermont
Vermont
$9K +$9.36K +285 New
Fifth Third Bancorp
111
Fifth Third Bancorp
Ohio
$6K +$6.57K +200 New
JIC
112
Joel Isaacson & Co
New York
$6K +$6.57K +200 New
TWA
113
TCI Wealth Advisors
Arizona
$5K +$5.25K +160 New
OWP
114
Obermeyer Wealth Partners
Colorado
$4K +$4.27K +130 New
RFC
115
Russell Frank Company
Washington
$3K +$3.28K +100 New
1 2 3 4
5

GHDX Hedge Fund Activity: Q2 2013 in Review

115 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q2 2013, worth a combined $858M.

Buyers outnumbered sellers: 115 funds opened new GHDX positions and 0 closed out — a net gain of 115 holders — while 0 added to existing stakes and 0 trimmed.

  • 115 institutional investors held Genomic Health, Inc. (GHDX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $858M of Genomic Health, Inc. stock for Q2 2013.
  • 115 funds opened new Genomic Health, Inc. positions in Q2 2013 and 0 closed out, a net change of +115 holders.

Based on aggregated 13F filings for Q2 2013.